+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Adenosine"

Adenosine receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 80 Pages
  • Global
From
Adenosine A2B receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A2B receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Adenosine Antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine Antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Adenosine A1 Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A1 Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adenosine A2A Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A2A Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adenosine A2A Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A2A Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A2 Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adenosine A3 Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A3 Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adenosine A3 Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A3 Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adenosine A1 Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A1 Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adenosine Triphosphate (ATP) Assays Global Market Report 2024 - Product Thumbnail Image

Adenosine Triphosphate (ATP) Assays Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
MTORC1 protein inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

MTORC1 protein inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Adenosine is a drug used in the treatment of endocrine and metabolic disorders. It is a purine nucleoside that acts as a neuromodulator, regulating the activity of various neurotransmitters and hormones. Adenosine is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to treat certain types of heart failure, as well as to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms. Adenosine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms, and is often prescribed in combination with other drugs. Some companies in the Adenosine market include Novartis, Merck, Pfizer, Sanofi, and GlaxoSmithKline. Show Less Read more